Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine Decanoate Injection, USP has not been shown effective in the management of behavioral complications in patients with mental retardation.
From the U.S. FDA-approved label for Fluphenazine. Full label: DailyMed.
Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine Decanoate Injection, USP has not been shown effective in the management of behavioral complications in patients with mental retardation.
From the U.S. FDA-approved label for Fluphenazine. Full label: DailyMed.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Fluphenazine decanoate injection may be given intramuscularly or subcutaneously. A dry syringe and needle of at least 21 gauge should be used.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Phenothiazines are contraindicated in patients with suspected or established subcortical brain damage. Phenothiazine compounds should not be used in patients receiving large doses of hypnotics. Fluphenazine decanoate injection is contraindicated in comatose or severely depressed states. The presence of blood dyscrasia or liver damage precludes the use of fluphenazine decanoate. Fluphenazine decanoate is not intended for use in children under 12 years of age.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fluphenazine decanoate injection is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING ). Tardive Dyskinesia: Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with neuroleptic (antipsychotic) drugs.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Central Nervous System: The side effects most frequently reported with phenothiazine compounds are extrapyramidal symptoms including pseudoparkinsonism, dystonia, dyskinesia, akathisia, oculogyric crises, opisthotonos, and hyperreflexia. Muscle rigidity sometimes accompanied by hyperthermia has been reported following use of fluphenazine decanoate.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
10 products from 10 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Anatensol Decanoate 25mg Injection | Fluphenazine (25mg) | Piramal Enterprises Ltd | vial of 1 ml Injection |
| Arkane 2mg Tablet | Fluphenazine (2mg) | Arvind Laboratories Pvt Ltd | strip of 10 tablets |
| F Tensil 25mg Injection | Fluphenazine (25mg) | Reliance Formulation Pvt Ltd | vial of 1 ml Injection |
| Fludecan 25mg Injection | Fluphenazine (25mg) | Maneesh Pharmaceuticals Ltd | vial of 2 ml Injection |
| Medipax 25mg Injection | Fluphenazine (25mg) | Alteus Biogenics Pvt Ltd | ampoule of 1 ml Injection |
| Monazine Injection | Fluphenazine (25mg) | Mova Pharmaceutical Pvt Ltd | vial of 1 ml Injection |
| Phenasol 25mg Injection | Fluphenazine (25mg) | Oxford Pharmaceuticals Pvt Ltd | vial of 1 ml Injection |
| Phenate 25mg Injection | Fluphenazine (25mg) | Mesmer Pharmaceuticals | ampoule of 1 ml Injection |
| Phenodec 25mg Injection | Fluphenazine (25mg) | Neon Laboratories Ltd | vial of 1 ml Injection |
| Phenvator 25mg Injection | Fluphenazine (25mg) | Ryon Pharma | vial of 1 Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Protect from light. Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
